Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience
At the Nanomedicine Innovation Center (NICE) at the Erasmus MC in Rotterdam, we have approached the treatment of cancer by starting with a vision of first establishing a platform that enables us to overcome the low levels of drugs delivered to tumors and the issue of dose-limiting toxicity. Showing...
Saved in:
Main Authors: | Mohamadreza Amin (Author), Ann L. B. Seynhaeve (Author), Majid Sharifi (Author), Mojtaba Falahati (Author), Timo L. M. ten Hagen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperthermia and Temperature-Sensitive Nanomaterials for Spatiotemporal Drug Delivery to Solid Tumors
by: Mohamadreza Amin, et al.
Published: (2020) -
Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides
by: Mohamadreza Amin, et al.
Published: (2022) -
Desiderius Erasmus of Rotterdam
by: Emerton, Ephraim, 1851-1935; Jackson, Samuel Macauley, 1851-1912 [Editor] -
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
by: Mehrdad Hashemi, et al.
Published: (2023) -
Editorial for Special Issue: "Liposomal and Lipid-Based Drug Delivery Systems and Vaccines"
by: Elena L. Vodovozova
Published: (2024)